Hollow Brook Wealth Management LLC Buys Shares of 54,172 Ralliant Corporation $RAL

Hollow Brook Wealth Management LLC purchased a new position in shares of Ralliant Corporation (NYSE:RAL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 54,172 shares of the company’s stock, valued at approximately $2,369,000.

Other institutional investors have also modified their holdings of the company. Manchester Capital Management LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at approximately $29,000. Westfuller Advisors LLC acquired a new stake in Ralliant during the 3rd quarter worth approximately $26,000. UMB Bank n.a. acquired a new stake in Ralliant during the 3rd quarter worth approximately $29,000. BOKF NA bought a new position in Ralliant in the third quarter valued at approximately $29,000. Finally, Webster Bank N. A. bought a new position in Ralliant in the third quarter valued at approximately $31,000.

Insider Activity

In other Ralliant news, Director Anelise Angelino Sacks purchased 2,000 shares of the business’s stock in a transaction on Monday, February 9th. The shares were purchased at an average cost of $41.25 per share, with a total value of $82,500.00. Following the transaction, the director directly owned 5,403 shares of the company’s stock, valued at $222,873.75. This represents a 58.77% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kate Mitchell acquired 2,350 shares of Ralliant stock in a transaction dated Tuesday, February 10th. The shares were acquired at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the purchase, the director owned 8,411 shares in the company, valued at approximately $357,299.28. The trade was a 38.77% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 8,145 shares of company stock worth $332,233.

Ralliant Price Performance

Shares of RAL opened at $42.34 on Monday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $57.02. The stock has a market capitalization of $4.73 billion and a P/E ratio of 21.60. The company has a 50 day moving average of $48.24 and a 200-day moving average of $46.76.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant’s revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.5%. The ex-dividend date is Monday, March 9th. Ralliant’s payout ratio is presently 10.20%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on RAL shares. Royal Bank Of Canada lowered their price objective on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research report on Friday, February 6th. Truist Financial cut their price objective on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Barclays reduced their target price on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research note on Monday, February 9th. Zacks Research cut Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Citigroup dropped their price target on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $50.50.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.